03:55 PM EDT, 03/28/2025 (MT Newswires) -- Health care stocks eased late Friday afternoon, with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.2%.

The iShares Biotechnology ETF (IBB) fell 1%.

In corporate news, a federal district court judge in New Jersey ordered Johnson & Johnson's ( JNJ ) Janssen Products unit to pay the US government $1.64 billion in damages and civil penalties after a jury found the unit liable for "unlawfully promoting" two HIV/AIDS drugs last year. Johnson & Johnson ( JNJ ) shares rose 0.5%.

Novartis ( NVS ) shares rose 1% after the US Food and Drug Administration approved h3 company's radioligand therapy Pluvicto for earlier use before chemotherapy in prostate cancer patients.

Milestone Pharmaceuticals ( MIST ) shares tumbled 61% after US Food and Drug Administration highlighted two issues regarding the company's new drug application for nasal spray etripamil for paroxysmal supraventricular tachycardia.

PTC Therapeutics ( PTCT ) shares fell 1.4% after the European Commission adopted the recommendation of the Committee for Medicinal Products for Human Use to not renew the marketing authorization the company's Translarna, a treatment for nonsense mutation Duchenne muscular dystrophy.